Discontinuation of disease modifying treatments in middle aged multiple sclerosis patients. First line drugs vs natalizumab
Fagius, Jan, Feresiadou, Amalia, Larsson, Elna-Marie, Burman, JoachimVolume:
12
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2017.01.009
Date:
February, 2017
File:
PDF, 261 KB
english, 2017